|4Jan 27, 11:04 AM ET

BioAmber Inc. 4

4 · BioAmber Inc. · Filed Jan 27, 2016

Insider Transaction Report

Form 4
Period: 2016-01-26
Hartmann Michael A.
Executive Vice President
Transactions
  • Award

    Stock Option (right to buy)

    2016-01-26+40,00040,000 total
    Exercise: $5.00Exp: 2026-01-26Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]The exercise price represents a premium of $0.86 per share over grant date closing market price of BioAmber Inc. common stock on the New York Stock Exchange of $4.14 per share
  • [F2]These options will vest as follows: 25% will vest on 01/26/2017; the remaining 75% will vest on a monthly basis over the three (3) following years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION